Search

everythinglearnresearchcommunity

for

Search:↓

Cyclosporine-A can cause excessive hair growth, which usually stops after discontinuing the drug.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.

An 81-year-old man's white hair began to regain its original color while he was treated with lenalidomide, suggesting that graying hair might be reversible.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

Mitochondrial dysfunction may contribute to chronic inflammation and immune system issues in Lichen planopilaris.

HPV genes and estradiol increase a cancer-related signaling pathway, which may be targeted for cervical cancer treatment.

Bimatoprost is effective for growing longer, thicker, and darker eyelashes.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

Botryococcus terribilis Ethanol Extract may reduce inflammation by changing gene expression in cells.

EGFR inhibitors often cause skin problems and other side effects, but these are usually reversible and can be managed to keep patients comfortable.

PRIDE syndrome includes skin and hair issues from cancer treatment with EGFR inhibitors.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

Hair growth is influenced by interactions between skin layers, growth factors, and hormones, but the exact mechanisms are not fully understood.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

Understanding hair growth involves complex interactions between molecules and could help treat hair disorders.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Ruxolitinib treatment led to unexpected hair regrowth in a patient with alopecia universalis.

Lasers can help reduce skin side effects from cancer treatment.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Cancer treatment drugs can cause permanent hair loss by damaging hair follicle stem cells, but a specific inhibitor might reverse this effect.

Intermittent isotretinoin can cause various skin, hair, and nail changes.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Blocking COX, especially COX-2, in the skin can reduce inflammation and pain and may help prevent skin cancer.

Cancer treatments can cause various eye problems, so eye doctors should know how to diagnose and treat these early.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.